Contacts: Marc Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700 ext.
Nick Kilsby, EKK PR (203) 406-8800 ext. 21
VISCOGLIOSI BROS., LLC APPOINTS DONALD GUTHNER TO MANAGE NEW CLINICAL
NEW YORK – April 29, 2004 – Viscogliosi Bros. LLC (VB),
a closely-held venture capital/private equity and merchant banking firm
focused on the musculoskeletal/orthopedics industry, has appointed Donald
W. Guthner as Vice President of Musculoskeletal Clinical Regulatory
Advisors, LLC (MCRA).
MCRA is a newly formed company whose mission is to enhance the value
of VB client companies and assist others by managing and advising on
clinical research and regulatory programs. MCRA will guide companies
through the complex and difficult pathways leading to U.S. FDA regulatory
approval of new products.
Focusing on orthopedic companies both within and outside VB’s
existing investment portfolio, MCRA is positioned to increase synergies
within the firm’s extensive network in the musculoskeletal/orthopedic
sector of the healthcare industry.
Mr. Guthner brings considerable expertise and experience in the complexities
associated with clinical and regulatory management. He has 25 years
of experience in Class III Medical Devices, most recently assisting
in the merger of Spine Solutions, Inc. (SSI) with Synthes-Stratec, Inc.’s
U.S. spine business. He was the clinical and regulatory director for
SSI during the post-merger transition period.
Mr. Guthner previously helped advance Synvisc® at Biomatrix, Inc
in Ridgefield, NJ, (now Genzyme, Inc.), and was the Director of Clinical
& Regulatory Affairs at Biolectron, Inc. when its SpinalPak®
bone growth stimulator received approval by FDA.
Before focusing on orthopedics, Mr. Guthner worked with the Ophthalmic
Medical Device divisions of Johnson and Johnson (IOLAB) and Alcon Laboratories,
Marc R. Viscogliosi, President of MCRA and a principal of VB, said:
"Don Guthner provided the inspiration for establishing MCRA, and
was the logical choice to lead the unit as a key element of our commitment
to offer a full range of services to help build and develop companies
in what is an exciting, dynamic sector of the healthcare market."
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. The have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases